Latest papers

Normal infant by a gestational carrier for a phenylketonuria mother: alternative therapy.

Effect of high maternal blood phenylalanine on offspring congenital anomalies and developmental outcome at ages 4 and 6 years: the importance of strict dietary control preconception and throughout pregnancy

Pregnancy experiences in the woman with mild hyperphenylalaninemia.

The National Institute of Child Health and Human Development and phenylketonuria.

The Maternal Phenylketonuria Project: a summary of progress and challenges for the future.

Maternal phenylketonuria: experiences from the United Kingdom.

Impact of the phenylalanine hydroxylase gene on maternal phenylketonuria outcome.

Role of nutrition in pregnancy with phenylketonuria and birth defects.

Historical background for the maternal PKU syndrome.

The Maternal Phenylketonuria International Study: 1984-2002.

Research design, organization, and sample characteristics of the Maternal PKU Collaborative Study.

Cognitive and behavioral development in maternal phenylketonuria offspring.

Relation of prenatal phenylalanine exposure to infant and childhood cognitive outcomes: results from the International Maternal PKU Collaborative Study.

Potential role of tetrahydrobiopterin in the treatment of maternal phenylketonuria.

Maternal phenylketonuria in Western Australia: pregnancy outcomes and developmental outcomes in offspring.

HIV in pregnancy.

Nutrient intake and congenital heart defects in maternal phenylketonuria.

From the Centers for Disease Control and Prevention. Barriers to dietary control among pregnant women with phenylketonuria--United States, 1998-2000.

Developmental neurotoxicity: do similar phenotypes indicate a common mode of action? A comparison of fetal alcohol syndrome, toluene embryopathy and maternal phenylketonuria.

Barriers to dietary control among pregnant women with phenylketonuria--United States, 1998-2000.